GC patients were found to display SCD1 overexpression, which was associated with SCD1-dependent increase of proliferation-related marker (PCNA), anti-apoptosis marker survivin, and anti-ferroptosis markers SLC7A11 and GPX4. Here, SCD is linked to gastric cancer.